2022-2029 年彈性體輸液泵全球市場

市場動態

彈性輸液泵的全球市場受到多種因素的推動，例如由於慢性病不斷增加，門診中心和醫院對彈性輸液泵的需求不斷增加、各種具有成本效益的新產品的推出以及新技術的進步。因素。

慢性病發病率的上升和各種新技術的進步預計將推動市場的增長。

市場的增長受到以下優勢的推動：小型和彈性泵的可用性、重量輕、一次性、便攜、易於操作、長期穩定性和藥物儲存、移動或不動。中心、醫院、診所和家庭護理中心正受到對彈性輸液泵不斷增長的需求的影響，並消除了人為錯誤的可能性。這些輸液泵可以放在小袋甚至口袋中攜帶，使其成為消費者的首選。彈性體輸液泵也更適合儲存。根據所用藥物的類型，這些泵可以很容易地冷凍或冷藏。此外，彈性輸液泵配有預裝管，可最大限度地降低額外成本。

越來越多地推出具有成本效益和方便的彈性輸液泵產品，預計將推動市場增長。例如，2021 年 4 月，B. Brown 將在一種生態系統中結合一種新型輸液泵，該生態系統提供多種好處，包括 OnlineSuiteplus 連接、數據管理、基於雲的應用程序以及卓越的治療和更新靈活性。 .

市場正在見證彈性輸液泵數字平台的技術進步。例如，Epic Medical Pte. Ltd. 的 SMARTeZ 泵可以通過彈性膜向具有正壓的患者輸送藥物。該泵由兩層矽膠膜組成，可在輸液完成時提高流量精度並減少殘留量。此外，彈性輸液泵配有移動應用程序 VSCAN 和 Chemo CS 應用程序，以改善不同地點或家中的患者治療效果。 VSCAN 可以評估泵中剩餘的藥物量。 SMARTeZ Chemo CS 應用程序可以通過其機載藥物庫幫助消除人為錯誤並提高患者安全性。

一些組織、協會和研究機構越來越多地提出改進彈性輸液泵和解決安全問題的舉措，預計將刺激市場增長。.例如，美國食品藥品監督管理局 (FDA) 發起了輸液泵改進計劃，以解決輸液泵安全問題，促進整個行業開發更安全、更有效的輸液泵。 FDA 為輸液泵製造商制定了額外的要求，以識別設計缺陷並在它們成為安全隱患之前及時糾正。作為上市前提交的一部分，它還提供了額外的設計和工程信息，並對設備進行了額外的測試。 FDA 與研究機構、外國監管機構和製造商合作，以促進更安全、更有效的輸液泵的開發。 FDA 正在提高醫院工作人員、管理人員和家庭用戶對減輕與使用現有輸液泵相關的風險的認識。

預計缺乏熟練的專業人員和軟件問題會阻礙市場增長。

市場因缺乏管理輸液泵的熟練人員而受到阻礙，例如填充藥物並以不同輸液速度和濃度使用的彈性輸液泵。此外，沒有藥房參與泵的製備和分配。與彈性輸液泵相關的其他問題包括軟件問題、警報錯誤、糟糕的用戶界面設計和損壞的組件，這些都會對市場造成嚴重破壞。

行業分析

全球彈性輸液泵市場根據各種行業因素（包括波特五力、監管分析、供應鏈分析和定價分析）對市場進行了深入分析。

全球彈性體輸液泵市場報告提供了大約 45 多個市場數據表、40 多個數字和 180 頁內容。

內容

第1章研究方法與範圍

• 調查方法
• 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

• 市場影響因素
  • 驅動程序
    • 慢性病發病率增加
    • 技術進步的增加
  • 限制因素
    • 缺乏熟練的員工和軟件錯誤
  • 商機
  • 影響分析

第5章行業分析

• 波特五力分析
• 監管分析
• 供應鏈分析
• 定價分析

第 6 章按產品類型分析

• 連續排放泵
• 變速泵

第 7 章按應用程序

• 疼痛管理
• 傳染病控制
• 化療
• 其他

第 8 章最終用戶

• 醫院和診所
• 門診護理
• 居家護理
• 其他

第 9 章按地區

• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 意大利
  • 西班牙
  • 其他歐洲
• 南美洲
  • 巴西
  • 阿根廷
  • 其他南美洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 其他亞太地區
• 中東和非洲

第 10 章競爭格局

• 主要發展和戰略
• 公司份額分析
• 按產品類型進行基準測試
• 值得關注的重點公司列表

第 11 章公司簡介

• B Braun Melsungen AG
  • 公司簡介
  • 按產品類型劃分的產品組合和內容
  • 主要亮點
  • 財務摘要
• Baxter International Inc.
• Halyard Health
• Heka Healthcare
• Nipro Medical Corporation
• Palex Medical SA
• Hospira Inc.（Pfizer Inc.）
• Pfm Medical AG
• Promecon GmbH
• Samtronic SA

第12章 彈性體輸液泵的全球市場-DataM

Market Overview

The Elastomer Infusion Pump Market size was valued US$ 1.03 billion in 2021 and is estimated to reach US$ 2.28 billion by 2029, growing at a CAGR of 8.7% during the forecast period (2022-2029).

The elastomer infusion pump is the medical device used to infuse medicines including antibiotics, chemotherapy, cytostatics, analgesics, local anesthetics, and others. It works by creating pressure by an elastomeric layer that that is molded into the inside of the pump. The elastomeric layer becomes stretched whenever the elastomeric pump is filled. It provides intermittent or constant infusions via the intravenous, intra arterially, epidurally, subcutaneous, perineural, intralesional, and another route of administration. It controls the flow rate's accuracy through the flow restrictor, which is molded into the system's tubing or placed within the elastomeric reservoir. The flow rate is increased or decreased whenever the elastomer infusion pump is placed above or below the patient.

Market Dynamics

The global elastomer infusion pump market is growing due to several factors such as rising demand for elastomer infusion pumps in an ambulatory centres and hospitals due to increasing prevalence of chronic disease, various new cost-effective product launches and novel technological advances.

Rising incidence of chronic diseases and various new technological advancements are expected to drive market growth.

The market growth is influenced by the rising demand for elastomer infusion pumps in an ambulatory or immobile centre, hospitals, clinics, and home care centres owing to their advantages such as neither gravity nor electricity-driven, availability of elastomeric pumps in a small size, lightweight, disposable, and portable, easy to operate, longer stability & storage of medicines, and eliminates the possibility of the human errors. These infusion pumps are the preferred choice for the consumers as they can be carried in a pouch or sometimes a pocket. The elastomer infusion pumps also provide storage advantages. These pumps can be easily frozen or refrigerated, depending on the type of medications being used. Moreover, the elastomer infusion pumps have pre-attached tubing that minimizes additional expenses.

The rise in the launch of cost-effective and convenient elastomeric infusion pump products shall boost the market growth. For instance, in April 2021, B. Braun had launched Spaceplus that is a novel infusion pump combined with OnlineSuiteplus a kind of ecosystem that provides various benefits including connectivity, data management, cloud-based applications, excellent therapy and update flexibility.

The market is witnessing technological advancement with the digital platforms for Elastomeric Infusion Pump. For instance, Epic Medical Pte. Ltd's SMARTeZ Pump allows the medication to be delivered to the patient by positive pressure applied by the elastomeric membrane. It comprises 2 layers of silicone membranes for improving the flow accuracy and reduces the residual volume when the infusion is complete. Moreover, the Mobile Apps are available along with this Elastomeric Infusion Pump to improve patient-user outcomes in alternate sites and at home VSCAN and Chemo CS App. VSCAN provides an assessment of the volume of medication remaining in the pump. SMARTeZ Chemo CS App helps eliminate human errors and improves patient safety with its onboard drug library.

The rising initiatives of several organizations, associations, and institutes to improve the elastomeric infusion pump and address the safety concerns shall stimulate market growth. For instance, the U.S. Food and Drug Administration (FDA) launched the infusion pump improvement initiative to address infusion pump safety problems and foster the development of safer, more effective infusion pumps across the industry. The FDA had established the additional requirements for infusion pump manufacturers to identify the design deficiencies and correct them timely before these deficiencies lead to safety problems. It had also provided the additional design and engineering information as part of their premarket submissions and conduct additional testing of their devices. The FDA had entered into a collaboration with the institutes, foreign regulatory bodies, and manufacturers to facilitate the development of safer and more effective infusion pumps. The FDA is creating awareness regarding mitigating the risks associated with using existing infusion pumps among hospital staff, administrators, and home users.

Scarcity of skilled professionals and software problems are expected to hamper the market growth.

The market is hindered by the lack of skilled staff to manage elastomeric infusion pumps, including filling the devices with medications and using varying infusion rates and concentrations. Moreover, there is a lack of pharmacy involvement in preparing and dispensing the pumps. The other issues associated with the elastomeric infusion pump are software problems, alarm errors, inadequate user interface design, damaged components, and others that could hurt the market.

Industry Analysis

The global elastomer infusion pump market provides in-depth analysis of the market based on various industry factors such as Porter's Five Forces, Regulatory Analysis, Supply Chain Analysis, Pricing Analysis.

Segment Analysis

Product type segment is expected to hold the largest market share in global elastomer infusion pump market

The elastomer infusion pump market is segmented into product types as continuous rate pumps and variable rate pumps. The continuous rate pumps account for the highest market share due to the high adoption of continuous rate elastomer infusion pumps to treat several diseases including cancer and chronic diseases as it provides efficient performance and stability. It is widely used for post-operative pain management. The market is dominated by the availability of several continuous rates of elastomer infusion pumps. For instance, Smiths Medical's Neofuser is a single-use, portable elastomeric infusion pump that provides the medication at a continuous pre-fixed flow. It is used to infuse chemotherapy, antibiotic therapy, analgesic therapy, and other general intravenous, intraarterial, subcutaneous, epidural, perineural, and intralesional infusions. Smith Medical's Neofuser Vario is a single-use, portable elastomeric multi-rate infusion pump used for systemic or regional preoperative and postoperative pain management therapy. It is available in different reservoir sizes to select 7 different flow rates and stop the flow with a detachable key.

The variable rate pumps segment is expected to have positive market growth owing to the rising uptake of patient-controlled analgesia (PCA) elastomeric pumps, i.e., elastomeric pumps with a bolus, as it enables to change the flow rate according to the individual pain relief requirements and effective in reducing the hospital stay and lowering the pain. For instance, Avanos Medical, Inc's On-Q Pump with Select-A-Flow Variable Rate Controller and On-demand Bolus Button is a non-narcotic elastomeric pump that automatically delivers a regulated flow of local anesthetic to a patient's surgical site or near nerves. It comprises the variable rate controller that provides the flow rate to be changed as per the patients' individual pain relief requirements and a bolus device that allows for breakthrough pain relief on demand by the patient or healthcare provider. This device has reduced the hospital stay by 1.1 days sooner, 69% lower pain scores, high satisfaction scores, and better pain management with fewer side effects.

Further, the market is also classified based on pain management, infection management, chemotherapy, etc. The pain management segment accounts for the highest market share due to the elastomer infusion pump's high usage to deliver both anesthetics and analgesics directly to the lesion or inflamed tissue. These devices help control acute pain and improve the patient's quality of life by maintaining its plasma level stability and analgesia. There is a rise in the approval of innovative and novel elastomer infusion pumps for pain management.

The chemotherapy segment is expected to have a positive market share due to an elastomer infusion pump's rising uptake for delivering chemotherapy. The increasing incidence of cancer as the elastomer infusion pump effectively delivers chemotherapy directly into the bloodstream and reducing the risk of developing occlusion. There is an increase in the number of companies developing the elastomer infusion pump for chemotherapy infusion. Halyard Health, Baxter International Inc, Epic Medical, Nipro Medical Corporation are the major players for the elastomer infusion pump for chemotherapy infusion. For instance, Nipro's Surefuser is a lightweight, single-use device for the safe delivery of chemotherapy treatments and other drugs administered intravenously. It reduces the risk of involuntary exposure to the medications. Halyard Health provides the home pump C-Series elastomer infusion pump for continuous infusion with delivery times ranging from 1 to 11 days for chemotherapy.

Geographical Analysis

North America region holds the largest market share in the global elastomer infusion pump market

By region, the elastomer infusion pump market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the elastomer infusion pump market due to high hospital stay with the rising prevalence of chronic diseases. According to the Agency for Healthcare Research and Quality (AHRQ), approximately more than seven million people are admitted to the hospital every year. Chronic diseases are the leading cause of mortality and morbidity. According to the Centres for Disease Control & Prevention (CDC), 2021 report approximately 6 out of 10 people have a chronic disease. Around 4 out of 10 people have two or more chronic diseases. More than 1 in 7 of US adults that is around 15% or 37 million adults are estimated to have CKD. 9 out of 10 people with CKD are unaware about their condition. The rise in the approval of the novel elastomer infusion pump products with technological advancement and product innovation & diversification shall stimulate market growth.

The Asia-Pacific market is expected to have positive market growth owing to the increase in the number of companies manufacturing the elastomer infusion pump. Manufacturers are focusing on bundling associated accessories and IV drugs to increase market penetration.

Developing countries such as China and India are expected to have substantial market growth owing to their increasing reliance on direct sales visits. The direct sales personnel also provide training to the staff and homecare settings to administer drugs to patients using elastomeric infusion pumps. The rising uptake of pain management drugs and chemotherapy drugs shall increase the elastomer infusion pump's demand. The rising number of post-operative early discharges from hospitals shall boost the demand for wearable disposable ambulatory elastomeric infusion pumps. Moreover, the growing adoption of elastomeric infusion pumps in-home care settings, especially for older adults, provides their homes' comfort. The growing awareness regarding the elastomer infusion pump shall fuel the market growth over the forecasted period.

Competitive Landscape

The elastomer infusion pump market is highly competitive with the presence of several international and local market players. Product diversification, cost-effective products, revenue generation, and opportunities intensify the market competition. B Braun Melsungen AG, Baxter International Inc, Halyard Health, Heka Healthcare, Nipro Medical Corporation, Palex Medical SA, and Hospira Inc (Pfizer Inc.) are the leading companies with a significant market share.

Companies are using technological advancement, product diversification, novel product development, and market expansion strategies. For instance, in February 2020, LTR Medical had entered into an exclusive distribution agreement with Woo Young Medical to distribute their new generation of elastomeric infusion technologies into the Australian market.

The companies enter into collaborations, mergers, strategic partnerships, and acquisitions to increase the demand for elastomer infusion pump and their expansion across the globe. For instance, in Nov 2020, Ambu Inc. announced their contract with Intalere that will work for pain care management solutions. Intlere is going to receive Ambu ACTion TM block pain pump.

Key Companies to Watch

B Braun Melsungen AG:

Overview: B. Braun is German company that manufactures medical and pharmaceuticals device. Headquartered in Melsungen, Germany and founded in 1839. They provide services in around 60 countries that employees around 63,000 people. They have aroubd 5,000 variety of healthcare products.

Product Type Portfolio:

Easypump ST/LT: These elastomeric infusion pumps are developed to provide clinicians with the alternative to give the patients pre-determined medication amounts with an accurate and continuous system. It can be used in hospital as well as home.

Key Developments: B. Braun announced today that US FDA cleared its SpaceStation MRI for Space infusion pumps to deliver continuous medication to patients within the MRI system.

The global elastomer infusion pump market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers:
    • 4.1.1.1. Rising Incidence of Chronic Diseases
    • 4.1.1.2. Increasing technological advancements
  • 4.1.2. Restraints:
    • 4.1.2.1. Lack of skilled staff and software errors
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Regulatory Analysis
• 5.3. Supply Chain Analysis
• 5.4. Pricing Analysis

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
  • 6.1.2. Market Attractiveness Index, By Product Type Segment
• 6.2. Continuous Rate Pumps
  • 6.2.1.1. Introduction
  • 6.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 6.3. Variable Rate Pumps

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 7.1.2. Market Attractiveness Index, By Application Segment
• 7.2. Pain Management
  • 7.2.1.1. Introduction
  • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Infection Management
• 7.4. Chemotherapy
• 7.5. Others

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
  • 8.1.2. Market Attractiveness Index, By End User Segment
• 8.2. Hospitals and Clinics
  • 8.2.1.1. Introduction
  • 8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Ambulatory Care
• 8.4. Home Care
• 8.5. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Italy
    • 9.3.6.5. Spain
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. Australia
    • 9.5.6.5. Rest of Asia Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Key Developments and Strategies
• 10.2. Company Share Analysis
• 10.3. Product Types Benchmarking
• 10.4. List of Key Companies to Watch

11. Company Profiles

• 11.1. B Braun Melsungen AG
  • 11.1.1. Company Overview
  • 11.1.2. Product Type Portfolio and Description
  • 11.1.3. Key Highlights
  • 11.1.4. Financial Overview
• 11.2. Baxter International Inc.
• 11.3. Halyard Health
• 11.4. Heka Healthcare
• 11.5. Nipro Medical Corporation
• 11.6. Palex Medical SA
• 11.7. Hospira Inc. (Pfizer Inc.)
• 11.8. Pfm Medical AG
• 11.9. Promecon GmbH
• 11.10. Samtronic SA

LIST NOT EXHAUSTIVE

12. Global Elastomer Infusion Pump Market - DataM

• 12.1. Appendix
• 12.2. About Us and End User
• 12.3. Contact Us